| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.6 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.036 | 0.6 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.6 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |